Outcomes with P2Y12 inhibitors after PCI according to CYP2C19 genotype - PACE-CME

Outcomes with PY inhibitors after PCI according to CYPC genotype

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Edoxaban as alternative to warfarin after bioprosthetic valve surgery
Edoxaban as alternative to warfarin after bioprosthetic valve surgery
AHA 2024
Edoxaban as alternative to warfarin after bioprosthetic valve surgery
- Chisato Izumi, MD, PhD
New ESC Guidelines for CCS and PAAD
New ESC Guidelines for CCS and PAAD
ESC Congress 2024
New ESC Guidelines for CCS and PAAD
- Pierre Sabouret, MD, PhD
Lower stroke risk with DOAC vs. aspirin in subclinical atrial fibrillation
Lower stroke risk with DOAC vs. aspirin in subclinical atrial fibrillation
AHA 2023
Lower stroke risk with DOAC vs. aspirin in subclinical atrial fibrillation
- Jeff Healey, MD
International survey of secondary prevention of CHD
International survey of secondary prevention of CHD
ESC Congress 2023
International survey of secondary prevention of CHD
- John W. McEvoy, MD, PhD
- Joris Holtrop, MD